Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 32% ± 19% | |
oligodendrocyte precursor cell | 6 studies | 28% ± 11% | |
oligodendrocyte | 6 studies | 31% ± 7% | |
endothelial cell | 5 studies | 39% ± 17% | |
interneuron | 5 studies | 45% ± 25% | |
GABAergic neuron | 4 studies | 37% ± 20% | |
plasma cell | 3 studies | 21% ± 6% | |
neuron | 3 studies | 26% ± 1% | |
granule cell | 3 studies | 26% ± 1% | |
epithelial cell | 3 studies | 29% ± 8% | |
ciliated cell | 3 studies | 25% ± 9% | |
lymphocyte | 3 studies | 23% ± 2% | |
astrocyte | 3 studies | 28% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 30% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 163.24 | 1413 / 1445 | 90% | 2.56 | 164 / 183 |
stomach | 97% | 159.20 | 350 / 359 | 55% | 1.26 | 156 / 286 |
breast | 100% | 339.71 | 458 / 459 | 47% | 1.06 | 521 / 1118 |
ovary | 100% | 418.47 | 180 / 180 | 35% | 0.63 | 151 / 430 |
lung | 99% | 205.00 | 572 / 578 | 34% | 0.93 | 396 / 1155 |
intestine | 100% | 220.93 | 962 / 966 | 30% | 0.69 | 157 / 527 |
pancreas | 100% | 210.66 | 328 / 328 | 22% | 0.34 | 40 / 178 |
uterus | 100% | 354.16 | 170 / 170 | 22% | 0.40 | 102 / 459 |
prostate | 100% | 250.84 | 244 / 245 | 20% | 0.39 | 98 / 502 |
brain | 91% | 162.39 | 2415 / 2642 | 27% | 0.52 | 193 / 705 |
thymus | 100% | 264.29 | 651 / 653 | 18% | 0.26 | 107 / 605 |
bladder | 100% | 183.95 | 21 / 21 | 15% | 0.43 | 74 / 504 |
kidney | 94% | 119.60 | 84 / 89 | 20% | 0.41 | 182 / 901 |
skin | 99% | 233.67 | 1797 / 1809 | 14% | 0.22 | 68 / 472 |
adrenal gland | 95% | 109.84 | 245 / 258 | 15% | 0.23 | 34 / 230 |
spleen | 100% | 165.46 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 250.51 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 244.79 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 83% | 99.30 | 711 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 39% | 99.40 | 364 / 929 | 0% | 0 | 0 / 0 |
muscle | 38% | 26.91 | 304 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 0.47 | 14 / 45 |
liver | 27% | 17.69 | 61 / 226 | 4% | 0.05 | 15 / 406 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.18 | 4 / 29 |
eye | 0% | 0 | 0 / 0 | 11% | 0.17 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005515 | Molecular function | protein binding |
Gene name | ANKRD36B |
Protein name | Ankyrin repeat domain-containing protein 36B Ankyrin repeat domain-containing protein 36B (CLL-associated antigen KW-1) Ankyrin repeat domain 36B |
Synonyms | |
Description | |
Accessions | I1Z9D2 ENST00000258459.12 [Q8N2N9-1] I1Z9D5 ENST00000708145.1 [Q8N2N9-1] Q8N2N9 ENST00000443455.5 [Q8N2N9-4] I1Z9D3 A0A087X1R3 ENST00000419390.2 ENST00000359901.9 [Q8N2N9-1] ENST00000708148.1 [Q8N2N9-4] ENST00000708143.1 [Q8N2N9-1] A0A087WX87 ENST00000438709.7 |